drugset
drugset / Trial / NCT07508501

Food-effect Study of Ammoxetine Hydrochloride Enteric-coated Tablets

NCT07508501 ↗

Phase 1 Completed 14 enrolled CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

This study is a single-center, randomized, open-label, two-period crossover design to evaluate the effect of food on the pharmacokinetic profile of ammoxetine hydrochloride enteric-coated tablets.

Timeline

Start
2023-02-08
Primary completion
2023-02-24
Completion
2023-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ammoxetine Unknown 40 mg Oral

Indications

No indication recorded.